NEW YORK (GenomeWeb) – A team of investigators at Oslo University in Hospital in Norway has developed a digital PCR-based assay for detecting urinary bladder cancer recurrence that they hope to finalize by year end. 

The test surveys patient urine samples for methylation markers associated with the disease, and is being developed as an alternative to invasive cystoscopy, the current standard of care.

Get the full story with
360Dx Premium

Only $95 for the
first 90 days*

A trial upgrade to 360Dx Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try 360Dx Premium now.

Already a 360Dx Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.